Skip to content
Medical Health Aged Care

Monash Expert: World Lupus Day – Friday 10 May

Monash University < 1 mins read

Awareness about the symptoms of and treatment for lupus are the focus of World Lupus Day tomorrow (Friday, 10 May). The potentially debilitating autoimmune disease has no cure, and there are no fully effective therapies.

Monash University researchers are working towards improved long-term outcomes for those living with the condition. About one in 1000 Australians has lupus, and rates are higher in First Nations communities. Nine in 10 people with lupus are female and most develop it aged 15-45. 

Available to comment:

Professor Eric Morand, Monash University Sub-Faculty of Clinical and Molecular Medicine Dean, Monash Health Rheumatology Unit Head, and Monash Lupus Clinic founder
Contact details: Phone +61 3 9903 4840 or media@monash.edu
Read more of Professor Morand’s commentary at Monash Lens

  • what lupus is
  • who it affects
  • symptoms
  • treatments

The following can be attributed to Professor Morand:

“Since starting Australia’s first dedicated lupus clinic at Monash Health in 2007, Monash has become a world leader in lupus research across every dimension from quality of life all the way back to fundamental laboratory research. Our culture of connecting patients, clinicians, and basic scientists in the same mission is making the lives of people who live with lupus better.”

For more Monash media stories visit our news & events site: monash.edu/news
For any other topics on which you may be seeking expert comment, contact the Monash University Media Unit on +61 3 9903 4840 or media@monash.edu

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.